Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M507Revenue $M0.8Net Margin (%)-2,495.1Altman Z-Score14.7
Enterprise Value $M454EPS $-2.7Operating Margin %-2,338.3Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-2,495.1Higher ROA y-yN
Price/Book9.610-y EBITDA Growth Rate %--Quick Ratio9.6Cash flow > EarningsN
Price/Sales2155-y EBITDA Growth Rate %--Current Ratio9.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-53.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-123.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OCUL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Versant Venture Capital III, L10% Owner 2015-06-15Sell320,000$227.45 view
Warden Charles MDirector, 10% Owner 2015-06-15Sell320,000$227.45 view
SVLSF IV, LLC10% Owner 2015-06-10Sell1,119,000$227.45 view
Versant Venture Capital III, L10% Owner 2015-06-10Sell427,000$227.45 view
Warden Charles MDirector, 10% Owner 2015-06-10Sell427,000$227.45 view
Polaris Venture Management Co.10% Owner 2015-02-02Sell500,000$29.5-19.86 view
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$1381.85 view
Sawhney AmarpreetPresident and CEO, 10% Owner 2014-07-30Buy76,922$1381.85 view
CHV II, L.P.10% Owner 2014-07-30Buy153,846$1381.85 view
Ankerud EricSee Remarks 2014-07-30Buy1,000$1381.85 view

Quarterly/Annual Reports about OCUL:

News about OCUL:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

More From Other Websites
Street Talk: SPWR, MU, URBN, BWLD & OCUL Jul 14 2015
Ocular Therapeutix™ to Participate at the Cantor Fitzgerald Inaugural Healthcare Conference Jun 30 2015
Ocular Therapeutix™ to Participate at the Cantor Fitzgerald Inaugural Healthcare Conference Jun 30 2015
5 Stocks Ready for Breakouts Jun 26 2015
Ocular Therapeutix™ Begins Enrollment in Phase 3 Clinical Trial for DEXTENZA™ for the Treatment... Jun 16 2015
Ocular Therapeutix™ Begins Enrollment in Phase 3 Clinical Trial for DEXTENZA™ for the Treatment... Jun 16 2015
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 11 2015
Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock Jun 04 2015
Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock Jun 04 2015
Ocular Therapeutix, Inc. Announces Proposed Public Offering of Common Stock Jun 02 2015
Ocular Therapeutix, Inc. Announces Proposed Public Offering of Common Stock Jun 02 2015
OCULAR THERAPEUTIX, INC Financials May 27 2015
Ocular Therapeutix Inc Earnings Call scheduled for 8:00 am ET today May 15 2015
Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of... May 15 2015
Q1 2015 Ocular Therapeutix Inc Earnings Release - Time Not Supplied May 15 2015
Ocular Therapeutix reports 1Q loss May 15 2015
Ocular Therapeutix reports 1Q loss May 15 2015
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 15 2015
Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of... May 15 2015
Analyst Issues 5 Potential Biotech Buyout Candidates May 14 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK